血葡萄糖依赖性胰岛素型多和正常血糖妇女的活性子素之间的关联
Isidora Salvatierra1, Javier Parada2, Rodrigo Cataldo3
1Departamento de Nutrición, Diabetes y Metabolismo, Escuela de Medicina, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Endocrine connections
|January 13, 2026
概括
葡萄糖依赖性胰岛素型多 (GIP) 水平与肥胖标志物和炎症相关. 餐后GIP显示了与肥胖相关的代谢问题的生物标志物的潜力,即使没有肥胖.
科学领域:
- 内分泌学 在内分泌学.
- 代谢健康 代谢健康
- 肥胖问题研究研究
背景情况:
- 葡萄糖依赖性胰岛素型多 (GIP) 是由营养摄入后的肠内分泌K细胞分泌的.
- GIP在葡萄糖平衡和营养代谢中发挥作用.
- 了解GIP与肥胖和炎症的关联对于代谢健康研究至关重要.
研究的目的:
- 评估血GIP对口服葡萄糖挑战的反应和与肥胖相关的人类学,炎症标志物和阿迪波金之间的横截面关联.
- 评估使用食后血GIP作为肥胖相关表型的生物标志物的可行性.
主要方法:
- 50名没有肥胖的正常血糖女性接受了口服葡萄糖耐受性测试 (OGTT).
- 一组由8名女性组成的子组参与了一项以粉为基础的食的可行性研究.
- 测量了禁食和食后血GIP,荷尔蒙,代谢物,阿迪波金和炎症生物标志物.
主要成果:
- 在OGTT后的GIP增量变化与腰围,禁食TNF-α和白细胞计数相关.
- 在增量GIP变化和禁食高分子量 (HMW) 氨酸之间观察到显著的反向关联.
- 这些关联在调整年龄和BMI后仍然显著.
结论:
- 餐后GIP水平与循环的HMW-adiponectin相反相关.
- 餐后血GIP是与增加脂肪相关的代谢障碍的合适生物标志物,即使在非肥胖个体中也是如此.
相关概念视频
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.2K
Hormones Regulating Blood Glucose
6.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.4K
Insulin: The Receptor and Signaling Pathways
2.7K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.7K
Glucagon-like Receptor Agonists
836
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
836
Insulin Secretory Vesicles
6.4K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.4K
Dipeptidyl Peptidase 4 Inhibitors
575
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
575


